Endothelial Dysfunction in Mice with Streptozotocin-induced Type 1 Diabetes Is Opposed by Compensatory Overexpression of Cyclooxygenase-2 in the Vasculature

被引:59
作者
Nacci, Carmela [1 ]
Tarquinio, Mariela [1 ]
De Benedictis, Leonarda [1 ]
Mauro, Annamaria [1 ]
Zigrino, Addolorata [1 ]
Carratu, Maria Rosaria [1 ]
Quon, Michael J. [2 ]
Montagnani, Monica [1 ]
机构
[1] Univ Bari, Dept Pharmacol & Human Physiol, Sch Med, I-70124 Bari, Italy
[2] Natl Ctr Complementary & Alternat Med, Diabet Unit, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
NITRIC-OXIDE SYNTHASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACTIVATED PROTEIN-KINASE; PROSTAGLANDIN-H SYNTHASE; SMOOTH-MUSCLE; HIGH GLUCOSE; GENE-EXPRESSION; UP-REGULATION; KAPPA-B; ISCHEMIA/REPERFUSION INJURY;
D O I
10.1210/en.2008-1069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular complications of diabetes result from endothelial dysfunction secondary to persistent hyperglycemia. We investigated potential compensatory mechanisms in the vasculature that oppose endothelial dysfunction in diabetes. BALB/c mice were treated with streptozotocin (STZ) to induce type 1 diabetes (T1D). In mesenteric vascular beds (MVBs), isolated ex vivo from mice treated with STZ for 1 wk, dose-dependent vasorelaxation to acetylcholine (ACh) or sodium nitroprusside was comparable with that in age-matched control mice (CTRL). By contrast, MVBs from mice treated with STZ for 8 wk had severely impaired vasodilator responses to ACh consistent with endothelial dysfunction. Pretreatment of MVBs from CTRL mice with nitric oxide synthase inhibitor nearly abolished vasodilation to ACh. In MVB from 1-wk STZ-treated mice, vasodilation to ACh was only partially impaired by L-N-omega-arginine methyl ester. Thus, vasculature of mice with T1D may have compensatory nitric oxide-independent mechanisms to augment vasodilation to ACh and oppose endothelial dysfunction. Indeed, pretreatment of MVBs isolated from 1-wk STZ-treated mice with NS-398[selective cyclooxygenase (COX)-2 inhibitor] unmasked endothelial dysfunction not evident in CTRL mice pretreated without or with NS-398. Expression of COX-2 in MVBs, aortic endothelial cells, and aortic vascular smooth muscle cells from STZ-treated mice was significantly increased (vs. CTRL). Moreover, concentrations of the COX-2-dependent vasodilator 6-keto-prostaglandin F-1 alpha was elevated in conditioned media from aorta of STZ-treated mice. We conclude that endothelial dysfunction in a mouse model of T1D is opposed by compensatory up-regulation of COX-2 expression and activity in the vasculature that may be relevant to developing novel therapeutic strategies for diabetes and its cardiovascular complications. (Endocrinology 150: 849-861, 2009)
引用
收藏
页码:849 / 861
页数:13
相关论文
共 89 条
[1]   Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2 [J].
Adderley, SR ;
Fitzgerald, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (08) :5038-5046
[2]   Type 2 diabetic mice have increased arteriolar tone and blood pressure - Enhanced release of COX-2-derived constrictor prostaglandins [J].
Bagi, Z ;
Erdei, N ;
Toth, A ;
Li, W ;
Hintze, TH ;
Koller, A ;
Kaley, G .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1610-1616
[3]  
Bagi Zsolt, 2006, Pharmacol Rep, V58 Suppl, P52
[4]   Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages [J].
Baker, CSR ;
Hall, RJC ;
Evans, TJ ;
Pomerance, A ;
Maclouf, J ;
Creminon, C ;
Yacoub, MH ;
Polak, JM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :646-655
[5]  
Bardell AL, 2001, J PHARMACOL EXP THER, V296, P252
[6]   Inhibition of protein kinase Cβ prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans [J].
Beckman, JA ;
Goldfine, AB ;
Gordon, MB ;
Garrett, LA ;
Creager, MA .
CIRCULATION RESEARCH, 2002, 90 (01) :107-111
[7]  
Belton O, 2000, CIRCULATION, V102, P840
[8]   Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis [J].
Belton, OA ;
Duffy, A ;
Toomey, S ;
Fitzgerald, DJ .
CIRCULATION, 2003, 108 (24) :3017-3023
[9]   Primary Prevention of Cardiovascular Disease in People With Dysglycemia [J].
Bianchi, Cristina ;
Miccoli, Roberto ;
Penno, Giuseppe ;
Del Prato, Stefano .
DIABETES CARE, 2008, 31 :S208-S214
[10]   Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning [J].
Bolli, R ;
Shinmura, K ;
Tang, XL ;
Kodani, E ;
Xuan, YT ;
Guo, YR ;
Dawn, B .
CARDIOVASCULAR RESEARCH, 2002, 55 (03) :506-519